Remote
Executive Director, Head of Bioanalytical Sciences
About this role
About Us We are developing potentially best-in-class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology – enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation – enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections.
Our newest candidate, DNTH312, is an internally developed, investigational, first-in-class, next-generation bifunctional fusion protein combining claseprubart and TACI to target potent inhibition of aC1s and BAFF/APRIL. DNTH312 aims to be Phase 1 ready by year end 2027. To learn more, please visit www.dianthustx.com and follow us on LinkedIn . About the Role The Executive Director, Head of Bioanalytical Sciences will lead the company’s bioanalytical strategy and execution across research, translational, and clinical development.
Reporting to the Senior Vice President, Clinical and Translational Development, this individual will serve as the senior scientific authority for bioanalytical and biomarker assays and a key partner to program teams, senior leadership, Regulatory, Quality, Clinical Pharmacology, and external collaborators. The successful candidate will combine deep assay expertise with strong people leadership, executive communication, and operational judgment.
The role is accountable for building a scalable function, ensuring assay readiness and data quality, and managing resources across internal headcount, CROs, specialty laboratories, and consultants. We are building a culture of individuals who hold our core principles at the center of our operations, with the goal to elevate the care of our patients’ lives. We are open to you working remotely. Key Responsibilities Define and execute the company-wide bioanalytical strategy, operating model, standards, and capability roadmap in alignment with portfolio priorities and development plans.